| First Author | Zhang XL | Year | 2021 |
| Journal | Oncogene | Volume | 40 |
| Issue | 23 | Pages | 3959-3973 |
| PubMed ID | 33986509 | Mgi Jnum | J:335784 |
| Mgi Id | MGI:6718716 | Doi | 10.1038/s41388-021-01827-0 |
| Citation | Zhang XL, et al. (2021) CTHRC1 promotes liver metastasis by reshaping infiltrated macrophages through physical interactions with TGF-beta receptors in colorectal cancer. Oncogene 40(23):3959-3973 |
| abstractText | Metastasis is a major cause of cancer-related deaths. Tumor-intrinsic properties can determine whether tumor metastasis occurs or not. Here, by comparing the gene expression patterns in primary colorectal cancer (CRC) patients with or without metastasis, we found that Collagen Triple Helix Repeat Containing 1 (CTHRC1) in primary CRC served as a metastasis-associated gene. Animal experiments verified that CTHRC1 secreted by CRC cells promoted hepatic metastasis, which was closely correlated with macrophage infiltration. Depletion of macrophages by liposomal clodronate largely abolished the promoting effect of CTHRC1 on CRC liver metastasis. Furthermore, we demonstrated that CTHRC1 modulated macrophage polarization to M2 phenotypes through TGF-beta signaling. A mechanistic study revealed that CTHRC1 bound directly to TGF-beta receptor II and TGF-beta receptor III, stabilized the TGF-beta receptor complex, and activated TGF-beta signaling. The combination treatment of CTHRC1 monoclonal antibody and anti-PD-1 blocking antibody effectively suppressed CRC hepatic metastasis. Taken together, our data demonstrated that CTHRC1 is an intrinsic marker of CRC metastasis and further revealed that CTHRC1 promoted CRC liver metastasis by reshaping infiltrated macrophages through TGF-beta signaling, suggesting that CTHRC1 could be a potential biomarker for the early prediction of and a therapeutic target of CRC hepatic metastasis. |
